ScholarIQanswers from OpenAlex

EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK

PaperCitations, authors & open-access status

EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK have?

ScholarIQcitation count

EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK has 3 citations in the OpenAlex counts ScholarIQ stores.

When was EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK published?

ScholarIQyear

EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK has 2022 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK?

ScholarIQoa status

EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK has bronze oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK?

ScholarIQdoi

The DOI for EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK is on the source record.

Open the DOI →

What is the OpenAlex record for EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK?

ScholarIQopenalex

The OpenAlex for EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK is on the source record.

Open the OpenAlex →